By Susan Brinkmann, OCDS
Staff Writer
In what may be the first “fruits” of President Obama’s decision to allow taxpayer funding of experimentation on embryos, General Electric (GE) has announced a new liaison with Geron Corporation to begin using embryonic stem cells for the purpose of testing toxic effects of drug treatments.
